Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer (Q59647328)
Jump to navigation
Jump to search
scientific article published on 01 November 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer |
scientific article published on 01 November 2003 |
Statements
Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer (English)
I Vergote
M J Piccart
K Bertelsen
G Stuart
J Cassidy
C Mangioni
E Simonsen
K James
S Kaye
R Blom
R Grimshaw
R Atkinson
K Swenerton
M Nardi
J Kaern
S Tumolo
P Timmers
J-A Roy
F Lhoas
B Lidvall
M Bacon
A Birt
J Andersen
J Paul
S Pecorelli
B Baron
1 November 2003
s2
0 references